DailyIQ
Last updated 8 minutes ago

FTV·Fortive Corporation

$.
+. (+.%)
After Hours
High
$62.17
Open
$60.67
Market Cap
18.74B
52W High
$64.56
Low
$60.41
P. Close
$61.69
P/E
35.06
52W Low
$46.34
Fwd P/E
19.02
DailyIQ Est.
-
Technical Score (1D)
82
BUY
News Sentiment
66
BULLISH
Fortive’s latest Q2 2026 earnings call, released just under eight hours ago, highlighted a rebound in data‑center demand and AI‑software sales that helped cushion weaker European markets. The company also reiterated its focus on non‑GAAP metrics and high‑margin industrial solutions, noting modest revenue growth but an uptick in operating margins. This dual narrative signals that Fortive’s diversified portfolio is delivering stability while its high‑margin segments are beginning to drive profitability gains. For the next ten trading days, the market will likely weigh how quickly the AI‑software momentum can translate into sustained revenue growth, especially as European demand remains uncertain. Investors should monitor the company’s upcoming guidance for 2027, which could clarify the trajectory of its capital discipline and operating‑leverage initiatives. The company’s emphasis on portfolio expansion suggests potential for incremental revenue from new industrial solutions, which could influence short‑term earnings expectations. Meanwhile, Onto Innovation’s record Q2 revenue, reported 19 hours ago, underscores robust demand for advanced packaging, a trend that could indirectly support Fortive’s industrial solutions if supply‑chain dynamics shift. Watch for any subsequent updates on Fortive’s backlog and capital‑allocation decisions, as these will provide clearer insight into whether the current margin improvements are sustainable. Additionally, keep an eye on European market developments, as any further weakness could erode the gains from data‑center and AI‑software growth. Finally, any changes in Fortive’s non‑GAAP metrics or guidance revisions will be critical to assess the company’s short‑term valuation and risk profile.
Earnings Summary
Fortive Corporation, a global technology firm headquartered in Everett, Washington, delivers advanced instrumentation, software, and services through its Intelligent Operating Solutions and Advanced Healthcare Solutions segments, supporting manufacturing, healthcare, utilities, and other critical infrastructure. In the most recent reporting cycle, the company posted Q3 2025 EPS of $0.68 and revenue of $1.027 billion, followed by Q4 2025 EPS of $0.90 and revenue of $1.122 billion, both up from the prior two quarters of $0.85/1.474 billion and $0.58/1.016 billion respectively; EPS and revenue rose 15 % and 9 % quarter‑over‑quarter, and the firm beat analyst estimates in both Q3 and Q4 after missing in Q1 and Q2, indicating a recent acceleration in earnings momentum. Historically, Fortive has experienced a YoY decline in revenue and EPS from Q4 2024 to Q4 2025, yet the 2025 fiscal year shows a clear rebound in quarterly performance, with consistent revenue growth and EPS beats in the latter half of the year, suggesting a potential shift in the company’s operating trajectory. Recent news highlights include Q2 2026 earnings that reported core revenue growth of 6.7 % YoY and a 12 % rise in adjusted EBITDA, a robust $3.42 billion share‑repurchase program that has bought back 55.5 million shares since 2022, and a majority stake acquisition of UV Smart to expand its healthcare disinfection portfolio; these developments underscore Fortive’s disciplined capital allocation and strategic diversification. Investors should watch for any revisions to the full‑year EPS guidance, changes in the buyback pace, and progress on the UV Smart integration, as well as the performance of the industrial solutions segment, which underpins the company’s revised outlook and could influence the next quarter’s earnings trajectory.

EPS

EstBeatMiss
$0.52$0.63$0.73$0.84$0.95Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$0.71 - -
Q2'26$0.71$0.74+4.8%
Q1'26$0.65$0.70+8.0%
Q4'25$0.85$0.90+6.5%
Q3'25$0.57$0.68+19.5%
Q2'25$0.59$0.58-2.1%

Revenue

EstBeatMiss
$1.0B$1.0B$1.1B$1.1B$1.1BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$1.1B - -
Q2'26$1.1B$1.1B+1.7%
Q1'26$1.0B$1.1B+1.9%
Q4'25$1.1B$1.1B+1.7%
Q3'25 - $1.0B -
Q2'25 - $1.0B -

Market Data

FTV Stock Snapshot

FTV is currently trading at $61.65, giving Fortive Corporation a market cap of 18.74B and a P/E ratio of 35.1. Today's range spans $60.41–$62.17, with shares opening at $60.67 and moving down $0.04 (0.1%) from the prior close. DailyIQ's technical score sits at 82/100 (BUY) with a news sentiment reading of 66/100.

Over the past year FTV has traded between $46.34 and $64.56 - the current price is +33.0% off the 52-week low and -4.5% from the high.

Fortive Corporation (FTV) is a large-cap in Technology with 18.74B in market cap, and the current setup is one of the cleaner bullish reads in the space. Technical score: 82/100 (BUY). Sentiment: bullish at 66/100. Price: $61.65 (in the upper portion of its 52-week range). The current P/E ratio stands at 35.1. The 52-week range of $46.34–$64.56 provides structural context - and the current technical/sentiment alignment is the type of setup that attracts both momentum and growth-oriented capital.

The combination of a BUY signal (82/100) and bullish news sentiment (66/100) puts FTV on the screens of active managers who run quality-momentum overlays — a cohort that can build meaningful positions at 18.74B in Technology market cap without immediately moving the stock. At $61.65 (in the upper portion of its 52-week range in the $46.34–$64.56 range), the entry discipline is clean and the potential re-rating if sentiment continues to improve is meaningful.

Last updated: August 8, 2026

Company Insights: Fortive Corporation (FTV)

Fortive Corporation (FTV) operates as a diversified technology company, providing essential products and services across its Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The company leverages well-established brands like Fluke and Gordian to serve critical industries including manufacturing, healthcare, and utilities. Fortive's strategic focus centers on optimizing operational efficiency, enhancing safety protocols, and improving clinical productivity for its global customer base.

Recent financial performance indicates a mixed earnings trajectory, with EPS beats observed in Q4 2024 and Q4 2025, contrasting with misses in Q1 and Q2 2025. Revenue trends have shown deceleration, moving from $1.62 billion in Q4 2024 down to $1.02 billion in Q3 2025, with a slight rebound to $1.12 billion in Q4 2025. This pattern suggests potential headwinds impacting top-line expansion despite some bottom-line outperformance.

A key concern for investors is the company's organic revenue growth, which has averaged a modest 1.8% over the past two years. While management highlights new product introductions and cost control measures, the persistent slow organic growth raises questions about underlying demand and competitive pressures. Monitoring future revenue performance and management's strategies to accelerate growth will be critical for assessing Fortive's outlook.

Earnings Consistency

Fortive has demonstrated an ability to exceed Earnings Per Share (EPS) expectations in specific quarters, notably Q4 2024 and Q4 2025.

However, the company has also experienced EPS misses in Q1 and Q2 2025, indicating variability in quarterly performance.

This inconsistency necessitates a close examination of the drivers behind both beats and misses to understand future earnings potential.

Revenue Growth

Recent revenue figures show a deceleration trend, with a notable decline from $1.62 billion in Q4 2024 to $1.02 billion in Q3 2025.

Organic revenue growth has averaged a slow 1.8% over the past two years, signaling potential challenges in expanding the top line.

Future performance hinges on the company's ability to re-accelerate revenue growth through new products and market penetration.

Valuation Metrics

Fortive currently trades with a Price-to-Earnings (P/E) ratio of approximately 29.67, suggesting a valuation that reflects growth expectations.

The 52-week trading range, from $46.34 to $76.54, indicates significant price volatility experienced by the stock.

Investors should assess whether the current valuation is justified by the company's growth prospects and historical performance.

Operational Focus

The company operates through two primary segments: Intelligent Operating Solutions and Advanced Healthcare Solutions.

Brands like Fluke and Gordian are key to delivering instrumentation, software, and services aimed at optimizing efficiency and safety.

Management commentary often emphasizes new product introductions and cost controls as levers for performance improvement.

Positioning FTV

Fortive Corporation (FTV) presents a complex investment profile characterized by mixed earnings results and concerns over organic revenue growth. Investors seeking exposure to the scientific and technical instruments sector might consider initiating or adding to positions during periods of significant price weakness, provided there is a clear catalyst for accelerated growth. Conversely, reducing exposure could be warranted if the company fails to demonstrate a sustainable path to higher organic revenue expansion or if macroeconomic headwinds intensify.

Key Metrics for FTV

Fortive's performance hinges on its ability to drive organic growth and maintain operational efficiency across its diverse industrial and healthcare segments. Investors should monitor key indicators that reflect demand trends and the company's execution.

Organic Revenue Growth: Measures revenue growth excluding acquisitions and divestitures. Accelerating organic growth signals strong underlying demand for Fortive's products and services; deceleration suggests headwinds. This is critical for FTV as it indicates the health of its core businesses and its ability to gain market share.

Segment Profitability: Tracks the operating profit generated by Fortive's Intelligent Operating Solutions and Advanced Healthcare Solutions segments. Expanding segment margins indicate effective cost management and pricing power; declining margins suggest cost pressures or competitive challenges. This metric is vital for FTV as it directly impacts overall profitability and cash flow generation.

Free Cash Flow: Represents the cash generated by Fortive after accounting for capital expenditures. Strong and growing free cash flow allows for reinvestment, debt reduction, and shareholder returns; declining FCF can signal operational issues. This is a key indicator of FTV's financial health and its capacity to create shareholder value.

New Product Revenue: Measures the contribution of recently launched products to Fortive's total revenue. Increasing new product revenue demonstrates FTV's innovation pipeline and ability to capture new market opportunities. This is important for Fortive's long-term growth prospects and its competitive positioning.

FTV Competitive Positioning

Fortive Corporation (FTV) is tracked alongside these names in Scientific & Technical Instruments on DailyIQ.

  • AAPL — Apple Inc.

  • ACN — Accenture plc

  • ADBE — Adobe Inc.

  • ADI — Analog Devices, Inc.

  • ADP — Automatic Data Processing, Inc.

Risk Factors

Fortive's risks stem from its reliance on specific industrial and healthcare markets, the execution of its growth strategies, and its ability to innovate. Investors should monitor these areas for potential impacts on financial performance.

  • Growth Deceleration

    Fortive has experienced a deceleration in organic revenue growth, averaging a slow 1.8% over the past two years. This indicates potential underlying demand weakness or challenges in expanding its existing business lines. If this trend continues, it could limit future revenue and profit expansion, impacting investor returns.

  • Healthcare Regulation

    The Advanced Healthcare Solutions segment faces risks associated with evolving healthcare regulations and reimbursement policies. Changes in these areas could impact demand for its sterilization and workflow solutions. Such regulatory shifts could materialize unexpectedly, affecting sales and profitability in this critical segment.

  • Integration Risk

    Fortive has a history of acquisitions. The successful integration of acquired businesses is crucial for realizing synergies and achieving projected growth. Failure to effectively integrate new companies could lead to operational inefficiencies and hinder the expected financial benefits, materializing if integration plans falter.

  • Macroeconomic Sensitivity

    As a supplier to manufacturing, utilities, and healthcare, Fortive's performance is tied to broader economic conditions. A significant economic downturn could reduce capital expenditures by its customers, impacting demand for its instruments and software. This risk would materialize during periods of recession or significant industrial slowdown.

  • Innovation Pace

    The technology and instrument markets require continuous innovation to maintain competitive advantage. If Fortive fails to keep pace with technological advancements or introduce compelling new products, its market share and pricing power could erode. This risk becomes more pronounced if competitors launch superior solutions first.

Analyst Price Targets for FTV

The current spread of analyst price targets and ratings for Fortive Corporation (FTV).

Consensus Target
$62.19
High Target
$72.0
Low Target
$51.0
Buy / Hold / Sell
6 / 16 / 2

Reflects the most recently tracked analyst ratings for FTV and may lag real-time updates. Not a recommendation to buy or sell.

FTV Recent Earnings History

  • Q4 2025

    EPS: $0.9 actual vs $0.85 estimate (beat) · Revenue: $1,122M actual vs $1,104M estimate

  • Q3 2025

    EPS: $0.68 actual vs $0.57 estimate (beat) · Revenue: $1,027M actual

  • Q2 2025

    EPS: $0.58 actual vs $0.59 estimate (miss) · Revenue: $1,016M actual

  • Q1 2025

    EPS: $0.85 actual vs $0.85 estimate (miss) · Revenue: $1,474M actual

  • Q4 2024

    EPS: $1.17 actual vs $1.12 estimate (beat) · Revenue: $1,620M actual

What Moves FTV Stock?

Fortive Corporation's stock performance is primarily driven by the demand for its specialized industrial and healthcare technologies, alongside its ability to achieve organic revenue growth. Investors closely monitor its operational efficiency and segment performance, particularly within Intelligent Operating Solutions and Advanced Healthcare Solutions.

Organic Growth Concerns

Fortive's organic revenue growth has been a key focus, with recent performance indicating a deceleration. Analysts and investors are scrutinizing the company's ability to generate top-line expansion amidst broader economic conditions and sector-specific challenges.

Slower organic growth can pressure the stock by signaling underlying demand weakness or competitive challenges. Any signs of acceleration or effective strategies to counter this trend are likely to be met with positive investor reaction.

Segment Performance

The company's two core segments, Intelligent Operating Solutions and Advanced Healthcare Solutions, are critical to its financial results. Performance in areas like testing and measurement tools (Fluke) and sterilization equipment (ASP) directly impacts revenue and profitability.

Strong execution and demand within these segments, supported by new product introductions, can drive earnings beats and stock appreciation. Conversely, weakness in either segment, perhaps due to supply chain issues or reduced capital expenditure by clients, can weigh on the share price.

Profitability & Efficiency

Fortive's operational efficiency and margin management are crucial for investor confidence, especially given its focus on profitable growth. The company's ability to control costs and maintain healthy operating margins is a key performance indicator.

Consistent margin expansion or strong profitability, even with moderate revenue growth, can support the stock's valuation. Any perceived erosion in margins or failure to meet efficiency targets may lead to investor concern and downward pressure on the stock.

Key insight: Fortive's stock hinges on its capacity to reignite organic revenue growth while maintaining strong operational efficiency across its key industrial and healthcare segments. Investor sentiment will likely remain sensitive to signs of accelerating top-line performance and margin resilience.

Frequently Asked Questions About FTV

Is Fortive Corporation (FTV) stock a good investment?

Fortive Corporation (FTV) operates in essential technology segments like Intelligent Operating Solutions and Advanced Healthcare Solutions. The company's focus on operational efficiency and safety solutions across various industries could provide a stable foundation. Investors might consider its diversified business model and brand portfolio when evaluating its investment potential.

What drives Fortive Corporation (FTV) stock price?

Fortive's stock price is influenced by the performance of its Intelligent Operating Solutions and Advanced Healthcare Solutions segments. Key drivers include demand for its instrumentation, software, and healthcare workflow solutions, as well as broader industrial and healthcare sector trends. Management's ability to drive organic growth and integrate acquisitions also plays a significant role.

Does Fortive Corporation (FTV) pay a dividend?

Yes, Fortive Corporation (FTV) pays a quarterly cash dividend to its shareholders. The company has a history of returning capital, which can be an attractive feature for income-focused investors. Investors should review the latest dividend declarations and payout history for current information.

What are the risks of investing in Fortive Corporation (FTV)?

Risks associated with Fortive Corporation (FTV) include potential slowdowns in the manufacturing and healthcare industries it serves, as well as competitive pressures. Macroeconomic factors and challenges in achieving consistent organic revenue growth are also considerations. The company's reliance on specific product cycles and technological advancements could also pose risks.

How is Fortive Corporation (FTV) valued?

Valuation for Fortive Corporation (FTV) can be assessed using metrics such as its price-to-earnings (P/E) ratio, which stands at approximately 29.67, and its market capitalization of around $17.18 billion. Investors often compare these figures to industry peers and the company's historical valuation multiples. Future growth prospects and profitability trends are key components in determining its current market value.

What is the investment thesis for Fortive Corporation (FTV)?

The investment thesis for Fortive Corporation (FTV) centers on its diversified portfolio of essential technology products and services, serving critical industries like manufacturing and healthcare. Its focus on operational efficiency and safety solutions, coupled with established brands like Fluke, provides a foundation for stable performance. Growth is expected to be driven by innovation, strategic acquisitions, and expanding market penetration in its key segments.

What are Fortive's (FTV) key growth strategies?

Fortive's (FTV) growth strategies often involve developing new products and enhancing existing ones within its Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The company also pursues strategic acquisitions to expand its technological capabilities and market reach. Furthermore, optimizing operational efficiency and cost controls are continually emphasized to drive profitability.

How does Fortive Corporation (FTV) perform in different economic cycles?

Fortive Corporation (FTV) operates in sectors that can be influenced by economic cycles, though its focus on essential products and services may offer some resilience. Demand for its industrial instrumentation and healthcare solutions can fluctuate with broader economic activity. Management's efforts to diversify revenue streams and maintain operational efficiency are key to navigating economic downturns.

What is Fortive's (FTV) outlook for organic revenue growth?

Recent analysis indicates that Fortive's (FTV) organic revenue growth has been relatively slow, averaging around 1.8% over the past two years. Investors are closely watching for management's strategies to accelerate this growth, particularly in light of concerns about weakening demand in certain sectors. Future performance will depend on the success of new product introductions and market expansion efforts.

How does Fortive Corporation (FTV) compare to its peers?

Fortive Corporation (FTV) operates in specialized segments within the technology sector, distinguishing it from broader tech giants like Apple or Microsoft. Its peers in scientific and technical instruments might include companies focused on similar niche markets. Investors often analyze Fortive's growth rates, profitability, and valuation multiples against these more direct competitors.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles